This Article  • Full text  • PDF  • Spanish PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Oncology  • Cervical Cancer  • JAMA Patient Page  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Half of all cancers of the cervix (the lower part of the uterus [womb]) occur in women between the ages of 35 and 55 years. Every year more than 11 000 women in the United States are diagnosed with invasive cervical cancer, and nearly 4 000 will die from complications of this disease. Cervical cancer is preventable and curable if detected early. The November 21, 2007, issue of JAMA includes an article describing the use of careful follow-up and an imaging test called fluorine-18-labeled deoxyglucose-positron-emission tomographic scan (FDG-PET), a nuclear medicine scan that detects uptake of glucose by tumor cells, to assess tumor response to therapy, to predict survival outcomes, and to detect early recurrence of tumor cells.

RISK FACTORS

• Human papillomavirus infection—various strains of the human papillomavirus (HPV), a sexually transmitted viral infection, play a role in causing most cases of cervical cancer. A vaccine is now available . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?